Natera Q3 2023 Earnings Presentation

Natera reported $268M in total Q3 2023 revenue with 27% YoY growth and 45% gross margin. The company raised full-year revenue guidance to $1,035M-$1,050M and expanded its clinical portfolio including Medicare coverage for FoundationOne Tracker and ongoing Phase III breast cancer trials.